COVID Vaccine

Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline

DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions

German Man Vaccinated Himself 217 Times Against COVID: Here's What Happened Next

DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions

German Man Vaccinated Himself 217 Times Against COVID: Here's What Happened Next

Why Is Gritstone Bio Stock Trading Lower?

Walgreens Bites The Covid Dust

Why Is Gritstone Bio Stock Trading Lower?

|

Walgreens Bites The Covid Dust

|

Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report

|

Boosters And Mandate Could Increase Vaccine Demand

Sponsored

COVID Vaccine Recent News

Everest Joins Race to Make mRNA Covid Vaccines for China

Key takeaways: Everest will pay up to $150 million or more to potentially bring an mRNA vaccine being developed by Canada’s Providence Therapeutics to China Deal comes as Beijing appears increasingly receptive to mRNA vaccines, even though Providence’s jabs have yet to be approved in its home Canada market By Richard Barbarossa

|

Air Canada Mandates Employee Vaccination Against COVID-19

|

Tuesday's Market Minute: Markets Rally On FDA Vaccine Approval

Investors may be scratching their heads at the resiliency shown by the major U.S. stock indices as of late. Despite the Delta variant unleashing renewed fears of economic shutdowns globally and other factors that should be dampening markets – supply chain issues, labor and semiconductor shortages, inflation – stocks remain at all-time-highs.

Sponsored

BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives FDA Clearance For mmRNA Oral Appliance

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

Sponsored

Pfizer's Unusual Options Spotted

Pfizer (NYSE:PFE) shares experienced unusual options activity on Friday. The stock price moved up to $49.6 following the option alert.

|

Moderna's Shot Seems To Have A Better Shot Against Delta Than Pfizer's

Besides proudly stating that its Covid-19 shot produced a "robust" antibody response against the highly contagious delta variant last Thursday, Moderna (NASDAQ: MRNA) also posted second-quarter financial results that beat Wall Street's expectations on both earnings and revenue.

Sponsored